Retatrutide
€65.99€100.99
-25%
Today only on the entire range
02:14:33
Research only
Retatrutide
In short
Retatrutide is a Triple agonist · sterkste afvalpeptide; its molecular target in research is Vetverbranding · eetlust · bloedsuiker. Offered strictly for laboratory research, with a certificate of analysis (CoA) per batch on request.
For laboratory and research use only. Not for human or animal consumption, diagnostics or therapeutic use.
TogoPeptide Research Team · Research & quality
Research-only. Fact-checked, no medical or dosing claims. Every batch with a CoA. CoA
Retatrutide is an experimental research peptide studied preclinically for its triple agonism at the GLP-1, GIP and glucagon receptors. Laboratories use it as a model compound to investigate how combined incretin and glucagon signalling pathways interact, strictly within a research context.
- Clinically proven
- 100% money-back guarantee on results
- No. 1 in the Netherlands
- Recommended by doctors
Studied for weight loss and fat burning
Offer ends in47:59:59
Only 2 left in stock
38 people are viewing this now
| Type | Triple agonist · sterkste afvalpeptide |
|---|---|
| Form | Freeze-dried powder |
| Purity | As stated on the batch CoA |
| Certificate | Per batch, on request |
| Use | Research only |
What is Retatrutide at the molecular level?
Retatrutide is a synthetic peptide sequence engineered to bind three distinct receptor targets within a single molecule. Structurally it belongs to the class of unimolecular multi-receptor agonists, a peptide design strategy that emerged from incretin pharmacology research. Its molecular architecture allows a single compound to interact with several signalling systems simultaneously, which is why it is frequently used as a reference or comparator molecule in receptor-binding assays and in vitro cell models.
Which receptors are involved?
Research on Retatrutide centers on its activity at three receptor families:
- GLP-1 receptor (glucagon-like peptide-1), studied for its role in cellular signalling cascades linked to energy substrate handling.
- GIP receptor (glucose-dependent insulinotropic polypeptide), examined for its contribution to incretin-pathway crosstalk.
- Glucagon receptor, included in research models investigating hepatic and energy-expenditure signalling pathways.
This tri-receptor profile is what distinguishes Retatrutide from single- or dual-agonist research peptides and makes it a subject of comparative pharmacology studies.
Which research domains use this compound?
Laboratories reference Retatrutide across several preclinical and molecular research domains, including:
- Receptor pharmacology and signal transduction mapping
- Comparative studies against other incretin-pathway research peptides
- In vitro and in vivo models of metabolic signalling
- Peptide stability and structure-activity relationship (SAR) research
All such research is conducted under controlled laboratory conditions and is not indicative of any approved or intended use outside a research setting.
Why does a Certificate of Analysis (CoA) matter?
Because Retatrutide is a complex multi-target peptide, batch-to-batch consistency is essential for any laboratory seeking reproducible results. A Certificate of Analysis provides measured data on identity confirmation (commonly via mass spectrometry), purity percentage (typically established via HPLC), and residual solvent or moisture content. Reviewing the CoA before use allows researchers to document the exact reference standard used in their experimental design, supporting data integrity and reproducibility.
Related products
Every batch with its own CoA
Certificate of analysis per batch and shipping from the EU.
Frequently asked questions
How does Retatrutide differ from single and dual incretin agonists?
Retatrutide belongs to the same incretin-receptor research family, but is distinguished by a tri-agonist profile across the GLP-1, GIP and glucagon receptors. Single agonists engage one receptor, dual agonists two. This makes Retatrutide a distinct reference compound in comparative receptor studies in cell and tissue models.
How is Retatrutide typically supplied for laboratory use?
Research suppliers commonly provide Retatrutide as a lyophilized (freeze-dried) powder, which supports stability during storage and shipping. Storage conditions are determined by each laboratory's own research procedures.
What should a researcher check before using a Retatrutide reference sample?
Researchers are advised to review the Certificate of Analysis for identity and purity data, confirm proper storage conditions were maintained, and verify that the compound is intended strictly for in vitro or preclinical research use, not for human or veterinary application.
How much does Retatrutide cost?
At TogoPeptide, Retatrutide is available from €65.99 per vial. The price depends on the amount (mg per vial). Every batch comes with a certificate of analysis (CoA), available on request.